Anti-CD19 [CAT-13.1E10]

Absolute Antibody

Anti-CD19 [CAT-13.1E10]

9

This antibody is recommended for targeting and analysis of B cells. CAT-13.1E10 was used as a part of a fusion molecule aimed at intracellular delivery of BINDI in order to establish a potential treatment method of EBV-positive B lymphoma in a xenograft mouse model (US20160376333A1).

Research Use Only

Monoclonal

CAT-13.1E10

CD19

CD19 molecule

B4, CVID3, B-lymphocyte antigen CD19, B-lymphocyte surface antigen B4, T-cell surface antigen Leu-12, differentiation antigen CD19

Human

IgG1

B-lymphocyte antigen CD19

This chimeric human antibody was made using the variable domain sequences of the original Mouse IgG1 format, for improved compatibility with existing reagents, assays and techniques.

Human

-20°C,2°C to 8°C

41116161